SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001127855-09-000170
Filing Date
2009-05-01
Accepted
2009-05-01 11:20:54
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 SINOVAC BIOTECH 20-F, 12.31.08 sinovac20f123108.htm 20-F 4290947
2 SINOVAC BIOTECH 20-F, LIST OF SUBSIDIARIES sinovacexh8_1.htm EX-8.1 5291
3 SINOVAC BIOTECH 20-F, CERTIFICATION 302, CEO sinovacexh12_1.htm EX-12.1 11356
4 SINOVAC BIOTECH 20-F, CERTIFICATION 302, CFO sinovacexh12_2.htm EX-12.2 11077
5 SINOVAC BIOTECH 20-F, CERTIFICATION 906, CEO sinovacexh13_1.htm EX-13.1 5554
6 SINOVAC BIOTECH 20-F, CERTIFICATION 906, CFO sinovacexh13_2.htm EX-13.2 6766
7 SINOVAC BIOTECH 20-F, GRAPHIC 1 sinovac_flowchart1.jpg GRAPHIC 36819
8 SINOVAC BIOTECH 20-F, GRAPHIC 2 sinovac_flowchart2.jpg GRAPHIC 58312
9 SINOVAC BIOTECH 20-F, GRAPHIC 3 sinovac_flowchart3.jpg GRAPHIC 39189
  Complete submission text file 0001127855-09-000170.txt   4518140
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F | Act: 34 | File No.: 001-32371 | Film No.: 09787562
SIC: 2834 Pharmaceutical Preparations